IOP Management in Today's Practice: The Age of Outflow (CE Monograph)

Activity Description and Purpose

To address the educational needs of optometrists, this case-based program will focus on elucidating the role of nitric oxide in eyes with glaucoma, providing strategies to achieve target intraocular pressure levels with newer topical agents that home in on the trabecular meshwork, and interpreting clinically relevant data supporting the efficacy and safety of these new agents.

Target Audience

This educational activity is intended for optometrists caring for patients with glaucoma.

Learning Objectives

Upon completion of this activity, participants will be better able to:

  • Describe the downstream signaling effects of nitric oxide in relation to glaucoma
  • Discuss the effects of nitric oxide on the trabecular meshwork
  • Apply data from clinical trials on agents for lowering intraocular pressure through outflow mechanisms
Course summary
Available credit: 
  • 2.00 COPE
Course opens: 
11/01/2019
Course expires: 
10/28/2022
Cost:
$0.00

Faculty

Michael Chaglasian, OD, FAAO
Chief of Staff
Illinois Eye Institute
Associate Professor
Illinois College of Optometry
Chicago, Illinois

Walter O. Whitley, OD, MBA, FAAO
Director, Optometric Services
Virginia Eye Consultants
Virginia Beach, Virginia

Disclosures

Michael Chaglasian, OD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; Alcon; Bausch & Lomb Incorporated; Carl Zeiss Meditec, Inc; Glaukos Corporation; Novartis Pharmaceuticals Corporation; and Reichert, Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; Bausch & Lomb Incorporated; Carl Zeiss Meditec, Inc; Glaukos Corporation; Novartis Pharmaceuticals Corporation; and Reichert, Inc; Contracted Research: Heidelberg Engineering GmbH; and Topcon Medical Systems, Inc.

Walter O. Whitley, OD, MBA, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Alcon; Allergan; Bausch & Lomb Incorporated; Carl Zeiss Meditec, Inc; and Johnson & Johnson Vision Care, Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Alcon; Allergan; Bausch & Lomb Incorporated; Carl Zeiss Meditec, Inc; and Johnson & Johnson Vision Care, Inc.

Editorial Support Disclosures

The planners and staff of MedEdicus LLC have no relevant commercial relationships to disclose.

Tony Realini, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; iSTAR; New World Medical, Inc; and Notal Vision.

Disclosure Attestation

Each of the contributing physicians listed above have attested to the following:

  1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
  2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
  3. that all reasonable clinical alternatives will be discussed when making practice recommendations.

Accreditation Statement

COPE approved for 2.0 CE credits for optometrists.
COPE Course ID: 65265-GL
COPE Course Category: Glaucoma

Administrator:

Product Usage in Accordance With Labeling

Please refer to the official prescribing information for each drug and/or device discussed in this activity for approved indications, contraindications, and warnings.

Grantor Statement

This continuing education activity is supported through an unrestricted educational grant from Bausch & Lomb Incorporated

Sponsored by

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the State University of New York College of Optometry, MedEdicus LLC, Bausch & Lomb Incorporated, or Review of Optometry.

This CE activity is copyrighted to MedEdicus LLC ©2019. All rights reserved. 185

Available Credit

  • 2.00 COPE

Price

Cost:
$0.00
Please login or register to take this course.

Clicking Register indicates that you have reviewed the CE information for this activity.

Learning Method and Medium

This educational activity consists of a supplement and twenty (20) study questions. The participant should, in order, read the learning objectives contained at the beginning of this supplement, read the supplement, answer all questions in the post test, and complete the Activity Evaluation/Credit Request form. To receive credit for this activity, please follow the instructions provided on the post test and Activity Evaluation/Credit Request form. This educational activity should take a maximum of 2.0 hours to complete.